Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Pharmacological Evaluation and Molecular Docking of Novel Synthesized Pyrazolopyrimidine Derivatives

Version 1 : Received: 7 October 2023 / Approved: 8 October 2023 / Online: 8 October 2023 (08:26:48 CEST)

How to cite: Bafail, R.; Samman, W.; Alsulaimany, M.; Aljohani, A. Pharmacological Evaluation and Molecular Docking of Novel Synthesized Pyrazolopyrimidine Derivatives. Preprints 2023, 2023100436. https://doi.org/10.20944/preprints202310.0436.v1 Bafail, R.; Samman, W.; Alsulaimany, M.; Aljohani, A. Pharmacological Evaluation and Molecular Docking of Novel Synthesized Pyrazolopyrimidine Derivatives. Preprints 2023, 2023100436. https://doi.org/10.20944/preprints202310.0436.v1

Abstract

A series of pyrazolopyrimidines derivatives 4– 11 were synthesized using 1-(6-(3-methoxyphenyl)-4-methylpyridazin-3-yl)-1H-pyrazolo [3,4-d] pyrimidin-4-amine 3 as a starting material. The detailed synthesis, structure assignments of the novel compounds based on chemical and spectroscopic evidence, spectroscopic data, pharmacological properties and molecular docking are reported. The pharmacological evaluation illustrated that many of these compounds have good analgesic, anti-inflammatory and antimicrobial activities.

Keywords

pharmacological evaluation; docking; anti-inflammatory; analgesic; antimicrobial

Subject

Chemistry and Materials Science, Medicinal Chemistry

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.